What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.
Resources
Faculty
Marla Dubinsky, MD
David P. Hudesman, MD, FACG, AGAF
Corey A. Siegel, MD, MS
Location and Time
Convention Center Room: Salon Ballroom H-J
Philadelphia Marriott, Philadelphia, PA
Monday, October 28, 2024 | 7:30–9:00 PM ET